149 related articles for article (PubMed ID: 38147113)
1. Laryngeal cancer diagnosis via miRNA-based decision tree model.
Arora A; Tsigelny IF; Kouznetsova VL
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1391-1399. PubMed ID: 38147113
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer.
Saito K; Inagaki K; Kamimoto T; Ito Y; Sugita T; Nakajo S; Hirasawa A; Iwamaru A; Ishikura T; Hanaoka H; Okubo K; Onozaki T; Zama T
PLoS One; 2013; 8(8):e71480. PubMed ID: 23967217
[TBL] [Abstract][Full Text] [Related]
3. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Tang Z; Wei G; Zhang L; Xu Z
Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer.
Zhang H; Chen Z; Huang Q; Guo Y; Wang M; Wu C
Cell Oncol (Dordr); 2023 Aug; 46(4):1015-1030. PubMed ID: 36964893
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach.
Cao Z; Guo Y; Ao Y; Zhou S
Future Oncol; 2020 Nov; 16(33):2723-2734. PubMed ID: 32812475
[TBL] [Abstract][Full Text] [Related]
6. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
7. Identification of core miRNA prognostic markers in patients with laryngeal cancer using bioinformatics analysis.
Huang GJ; Yang BB
Eur Arch Otorhinolaryngol; 2021 May; 278(5):1613-1626. PubMed ID: 32789639
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.
Ayaz L; Görür A; Yaroğlu HY; Ozcan C; Tamer L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1499-506. PubMed ID: 23817697
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.
Cao P; Zhou L; Zhang J; Zheng F; Wang H; Ma D; Tian J
Head Neck; 2013 May; 35(5):720-8. PubMed ID: 22605671
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
11. Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data.
Wang Y; Chen M; Tao Z; Hua Q; Chen S; Xiao B
Cancer Genet; 2013; 206(9-10):340-6. PubMed ID: 24238754
[TBL] [Abstract][Full Text] [Related]
12. A miRNA signature suggestive of nodal metastases from laryngeal carcinoma.
Ricciardiello F; Capasso R; Kawasaki H; Abate T; Oliva F; Lombardi A; Misso G; Ingrosso D; Leone CA; Iengo M; Caraglia M
Acta Otorhinolaryngol Ital; 2017 Dec; 37(6):467-474. PubMed ID: 29327732
[TBL] [Abstract][Full Text] [Related]
13. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Sherafatian M
Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
[TBL] [Abstract][Full Text] [Related]
14. Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.
Lv Y; Wang Y; Zhang Z
Hum Cell; 2023 Jan; 36(1):76-97. PubMed ID: 36181662
[TBL] [Abstract][Full Text] [Related]
15. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
[TBL] [Abstract][Full Text] [Related]
16. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of a microRNA-pair signature in laryngeal squamous cell carcinoma patients.
Zhou S; Meng Q; Wang Z
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4451-4460. PubMed ID: 35478043
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNAs expression in laryngeal cancer.
Yu X; Li Z
Oncotarget; 2015 Sep; 6(27):23297-305. PubMed ID: 26079642
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miRNA-26b inhibits cancer proliferation of laryngeal carcinoma through autophagy by targeting ULK2 and inactivation of the PTEN/AKT pathway.
Wang S; Guo D; Li C
Oncol Rep; 2017 Sep; 38(3):1679-1687. PubMed ID: 28713931
[TBL] [Abstract][Full Text] [Related]
20. Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact.
Takeuchi T; Kawasaki H; Luce A; Cossu AM; Misso G; Scrima M; Bocchetti M; Ricciardiello F; Caraglia M; Zappavigna S
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
